Coynault C, Norel F
Institut Pasteur, Unité de Génétique des Bactéries Intracellulaires, 28 rue du Docteur Roux, Paris, Cedex 15, 75724, France.
Microb Pathog. 1999 Jun;26(6):299-305. doi: 10.1006/mpat.1999.0273.
Salmonella typhimurium rpoS and rpoS aroA mutants are effective live vaccines in the murine model of salmonellosis (Coynault et al., Mol. Microbiol. 1996; 22: 149-60). Here, we further investigate the characteristics of these vaccines. The systemic humoral response induced by S. typhimurium rpoS, aroA and rpoS aroA vaccine candidates against S. typhimurium LPS was studied by ELISA. In BALB/c mice, the rpoS aroA strain induced a systemic anti-LPS humoral response similar to that induced by the rpoS and aroA strains. The virulence of aroA and rpoS aroA vaccines in nude (nu/nu) BALB/c mice was also compared. Salmonella typhimurium aroA and rpoS aroA vaccines both produced slowly progressing lethal infections in athymic mice inoculated i.p. but the rpoS aroA strain was more attenuated than the aroA strain, as determined by time to death and bacterial counts in spleens. Finally, a rpoS mutant of Salmonella dublin conferred protection in mice against an oral challenge with a wild-type strain of S. dublin whereas a rpoS mutant of S. typhimurium did not. This suggests that the protection provided by the S. typhimurium rpoS vaccine is serotype-dependent.
鼠伤寒沙门氏菌rpoS和rpoS aroA突变体在鼠伤寒沙门氏菌病的小鼠模型中是有效的活疫苗(Coynault等人,《分子微生物学》,1996年;22: 149 - 160)。在此,我们进一步研究这些疫苗的特性。通过酶联免疫吸附测定法(ELISA)研究了鼠伤寒沙门氏菌rpoS、aroA和rpoS aroA候选疫苗针对鼠伤寒沙门氏菌脂多糖诱导的全身体液反应。在BALB/c小鼠中,rpoS aroA菌株诱导的全身抗脂多糖体液反应与rpoS和aroA菌株诱导的相似。还比较了aroA和rpoS aroA疫苗在裸(nu/nu)BALB/c小鼠中的毒力。鼠伤寒沙门氏菌aroA和rpoS aroA疫苗在腹腔注射接种的无胸腺小鼠中均产生进展缓慢的致死性感染,但根据死亡时间和脾脏中的细菌计数确定,rpoS aroA菌株比aroA菌株的减毒程度更高。最后,都柏林沙门氏菌的rpoS突变体在小鼠中对都柏林沙门氏菌野生型菌株的口服攻击提供了保护,而鼠伤寒沙门氏菌的rpoS突变体则没有。这表明鼠伤寒沙门氏菌rpoS疫苗提供的保护是血清型依赖性的。